TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $7,271,000 | -47.0% | 49,065 | -45.0% | 0.13% | -50.2% |
| Q3 2014 | $13,715,000 | -2.9% | 89,138 | -11.5% | 0.27% | +2.3% |
| Q2 2014 | $14,124,000 | +27.2% | 100,711 | +0.6% | 0.26% | +25.8% |
| Q1 2014 | $11,108,000 | +14.9% | 100,072 | +2.4% | 0.21% | +16.8% |
| Q4 2013 | $9,665,000 | +63.9% | 97,729 | +26.0% | 0.18% | +57.0% |
| Q3 2013 | $5,896,000 | – | 77,583 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |